FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: The role of dual-time-point imaging. A case presentation and review of the literature

Annals of Nuclear Medicine

Volumn 24, Issue 7, 2010, Pages 549-553

  Kitapci, Mehmet Tevfik ^a,b   Akkaş, Burcu Esen ^d   Gullu, Ibrahim ^c   Sokmensuer, Cenk ^c  

^a GAZI UNIVERSITY   (Turkey)

^b Integra Medical Imaging Center   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d NONE

Author keywords

Dual time point imaging; Epithelioid hemangioendothelioma; Fluorodeoxyglucose; Liver; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG UPTAKE; HEMANGIOENDOTHELIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER METASTASIS; LIVER TUMOR; MALE; PRIORITY JOURNAL; TUMOR LOCALIZATION;

BIOLOGICAL TRANSPORT; FLUORODEOXYGLUCOSE F18; HEMANGIOENDOTHELIOMA, EPITHELIOID; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78149361728     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-010-0379-5     Document Type: Article

References (16)

1. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982;50(5):970-81.
2. Ishak KG, Sesterhenn IA, Goodman ZD, Rabin L, Stromeyer FW. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol. 1984;15(9):839-52.
3. Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer. 1999;85(3):562-82.
4. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer. 2006;107(9):2108-21 (Review).
5. Lyburn ID, Torreggiani WC, Harris AC, Zwirewich CV, Buckley AR, Davis JE, et al. Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol. 2003;180(5):1359-64.
6. Rest CC, Botton E, Robinet G, Conan-Charlet V, Bizais Y, Visvikis D. FDG PET in epithelioid hemangioendothelioma. Clin Nucl Med. 2004;29(12):789-92.
7. Nguyen BD. Epithelioid Hemangiendothelioma of the liver with F-18 FDG PET imaging. Clin Nucl Med. 2004;29(12):789-92.
8. Lin E, Agoff N. Recurrent hepatic epithelioid hemangiendothelioma detection by FDG PET/CT. Clin Nucl Med. 2007;32(12):949-51.
9. Läuffer JM, Zimmermann A, Krähenbühl L, Triller J, Baer HU. Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor. Cancer. 1996;78(11):2318-27.
10. Demetris AJ, Ninervini M, Raikow RB, Lee RG. Hepatic epithelioid hemangioendothelioma: biological questions based on pattern of recurrence in an allograft and tumor immunophenotype. Am J Surg Pathol. 1997;21:263-70.
11. Munk OL, Bass L, Roelsgaard K, Bender D, Hansen SB, Keiding S. Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling. J Nucl Med. 2001;42:795-801.
12. Brix G, Ziegler SI, Bellemann ME, Doll J, Schosser R, Lucht R, et al. Quantification of [(18) F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply. J Nucl Med. 2001;42(8):1265-73.
13. Dirisamer A, Halpern BS, Schima W, Heinisch M, Wolf F, Beheshti M, et al. Dual-time-point FDG-PET/CT for the detection of hepatic metastases. Mol Imaging Biol. 2008;10(6):335-40.
14. Kuker RA, Mesoloras G, Gulec SA. Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease. Int Semin Surg Oncol. 2007;4:17.
15. Nishiyama Y, Yamamoto Y, Fukunaga K, Kimura N, Miki A, Sasakawa Y, et al. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med. 2006;47(4):633-8.
16. Akbulut A, Akkas BE, Gokcora N, Karabacak NI, Kitapci MT. The value of late phase imaging with 18F-FDG-PET/CT for liver metastases. Eur J Nucl Med. 2005; Suppl 1:97.